Hao Yuan | Veterinary Science and Veterinary Medicine | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Hao Yuan
South China Agricultural University

Hao Yuan
Affiliation South China Agricultural University
Country China
Scopus ID 57419792800
Documents 21
Citations 130
h-index 5
Subject Area Veterinary Science and Veterinary Medicine
Event International Forensic Scientist Awards

Hao Yuan is a researcher affiliated with South China Agricultural University whose scholarly activities focus on veterinary science, parasitology, immunology, infectious diseases, and host–pathogen interactions. His publication record demonstrates contributions to understanding the biological mechanisms of zoonotic pathogens, vaccine development, immune regulation, and disease pathogenesis in animals and experimental models. Through collaborative investigations involving Toxoplasma gondii, viral respiratory diseases, and neuroimmunology disorders, Hao Yuan has contributed to contemporary veterinary and biomedical research while supporting advances in animal health and translational science.[1]

Abstract

This article summarizes the academic profile and research achievements of Hao Yuan. His work spans veterinary medicine, parasitology, immunology, and infectious disease biology, with emphasis on pathogen-host interactions and disease prevention strategies. Recent studies include investigations of Toxoplasma gondii pathogenesis, vaccine efficacy, neuroimmune consequences of coinfections, and viral respiratory diseases affecting wildlife species. These contributions support scientific understanding of animal health and emerging infectious diseases.[2]

Keywords

Veterinary Science, Toxoplasma gondii, Immunology, Parasitology, Vaccines, Infectious Diseases, Host–Pathogen Interaction, Animal Health, Neuroimmunology, Veterinary Medicine.

Introduction

Veterinary biomedical research plays an important role in safeguarding animal health and addressing zoonotic disease challenges. Hao Yuan has participated in multidisciplinary studies exploring immune regulation, pathogen virulence mechanisms, vaccine development, and disease progression. His research contributes to a broader understanding of how infectious agents influence physiological and immunological responses across diverse animal systems.[3]

Research Profile

With 21 indexed publications, 130 citations, and an h-index of 5, Hao Yuan has developed a research portfolio centered on veterinary medicine and pathogen biology. His work frequently involves collaborative investigations examining molecular pathways associated with infection, inflammation, vaccine-induced immunity, and host defense mechanisms. These studies have appeared in recognized international journals spanning parasitology, immunology, virology, and biological sciences.[1]

Research Contributions

  • Investigated the protective role of arachidonic acid in alleviating intestinal injury induced by Toxoplasma gondii infection.[2]
  • Contributed to characterization of a red panda amdoparvovirus and identification of determinants associated with acute lung injury.[3]
  • Participated in studies examining behavioral and neurocognitive consequences of coinfection involving Porphyromonas gingivalis and Toxoplasma gondii.[4]
  • Supported evaluation of recombinant GRA12 vaccine candidates for protection against toxoplasmosis in domestic cats.[5]
  • Investigated molecular mechanisms by which Toxoplasma proteins influence inflammasome activity and tumor immunity pathways.[6]

Publications

  • The gut metabolite arachidonic acid alleviates intestinal injury induced by a Toxoplasma gondii strain isolated from a wild rodent (2026).
  • Isolation and characterization of a red panda amdoparvovirus causing fatal respiratory disease (2026).
  • Coinfection of Porphyromonas gingivalis and Toxoplasma gondii impairs neurocognitive function and induces anxiety-like behavior in rats (2026).
  • Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats (2025).

Research Impact

The research contributions associated with Hao Yuan support ongoing efforts to improve disease prevention, pathogen surveillance, and immunological understanding within veterinary science. His collaborative work bridges molecular biology and applied veterinary medicine, providing evidence that may inform future therapeutic and preventive strategies. The citation record and publication activity indicate growing scholarly engagement with his research outputs.[1]

Award Suitability

Hao Yuan demonstrates attributes commonly associated with recognition through the Innovative Research Award. His participation in studies addressing infectious disease mechanisms, vaccine development, host immunity, and pathogen-induced pathology reflects a commitment to advancing scientific knowledge. The interdisciplinary nature of his research and publication record supports consideration within international academic recognition programs dedicated to scientific innovation and research excellence.

Conclusion

Hao Yuan has established a developing academic profile within veterinary science through contributions to parasitology, immunology, and infectious disease research. His publications highlight involvement in investigations with relevance to animal health, pathogen biology, and translational biomedical science. Continued research activity is expected to further strengthen his impact within the veterinary and life sciences communities.

References

  1. Elsevier. (n.d.). Scopus author details: Hao Yuan, Author ID 57419792800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57419792800
  2. Yuan, H., et al. (2026). The gut metabolite arachidonic acid alleviates intestinal injury induced by a Toxoplasma gondii strain isolated from a wild rodent. Parasites & Vectors.
    https://doi.org/10.1186/s13071-026-07389-y
  3. Yang, L., Nie, L., Ren, H., He, H., Yuan, H., et al. (2026). Isolation and characterization of a red panda amdoparvovirus causing fatal respiratory disease. Virulence.
    https://doi.org/10.1080/21505594.2026.2658906
  4. Cao, H., Lin, J., Wei, W., Luo, J., Yuan, H., et al. (2026). Coinfection of Porphyromonas gingivalis and Toxoplasma gondii impairs neurocognitive function. Frontiers in Immunology.
    https://doi.org/10.3389/fimmu.2026.1728337
  5. Yang, J., Nie, L., Song, Y., Yuan, H., et al. (2025). Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats. Vaccines.
    https://doi.org/10.3390/vaccines13080851
  6. Yang, K., Song, Y., Yuan, H., Yang, Z. (2025). The Toxoplasma surface SRS14A promotes ASC ubiquitination to suppress AIM2 inflammasome and tumor immunity. International Journal of Biological Macromolecules.
    https://doi.org/10.1016/j.ijbiomac.2025.145343

Rasha Elsabagh | Veterinary Science and Veterinary Medicine | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Rasha Elsabagh | Veterinary Science and Veterinary Medicine | Research Excellence Award

Animal Health Research Institute (AHRI) | Egypt

Dr. Rasha Elsabagh is a distinguished cancer immunology and stem cell researcher recognized for her extensive expertise in cancer stem cells, immunotherapy, cell-mediated immunity, and plasmonic photothermal therapy. Her work integrates immuno-oncology, stem cell biology, and bio-nanotechnology, emphasizing innovative therapeutic strategies that target tumor-infiltrating immune cells and malignant stem cell populations. Dr. Rasha Elsabagh has made significant contributions to the field through high-impact publications in journals such as Veterinary Oncology, Stem Cell Research & Therapy, Advances in Animal and Veterinary Sciences, and proceedings of the German Stem Cell Network (GSCN), highlighting her pioneering studies on Gold Nano-Rod–mediated plasmonic photothermal therapy in feline mammary carcinoma, quantitative flow cytometry assessment of feline circulatory breast cancer stem cells, and characterization of short cell-cycle duration as a defining feature of human epidermal stem cells. Her research encompasses nano-enabled cancer therapeutics, hematopoietic stem cell differentiation, tumor microenvironment modulation, and RNA-based nanoparticle delivery systems for myeloid cell reprogramming, reflecting a strong focus on translational and precision approaches to cancer treatment. Through international collaborations in Europe and the United States, she has advanced stem cell imaging, immunophenotyping, and multimodal therapeutic evaluation techniques. Dr. Rasha Elsabagh’s contributions have been recognized through competitive fellowships and awards, including a prestigious postdoctoral fellowship from France (IFE–STDF), a USAID-funded research training scholarship, and the GSCN travel award. By presenting her findings at leading international conferences and driving interdisciplinary research initiatives, she continues to advance the frontiers of immunotherapy innovation, stem cell science, and translational cancer research, establishing herself as a prominent leader in her field.

Profile: ORCID

Featured Publications

  • Elsabagh, R. H., Farghali, H. A., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2025). Gold nano-rod (AuNR)-mediated plasmonic photothermal therapy in feline mammary carcinoma: Assessing metastatic and nonmetastatic outcomes. Veterinary Oncology.

  • Xiao, T., Eze, U. C., Charruyer-Reinwald, A., Weisenberger, T., Khalifa, A., Abegaze, B., Schwab, G. K., Elsabagh, R. H., Parenteau, T. R., & Kochanowski, K. et al. (2024). Short cell cycle duration is a phenotype of human epidermal stem cells. Stem Cell Research and Therapy.

  • Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2022). Prevention of in situ recurrence and distant metastasis in feline mammary carcinoma treated with plasmonic photothermal therapy. Research Square.

  • Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Ragab, E., Nada, A. A., & Selim, S. A. (2021). Quantitative flow cytometry assessment of feline circulatory breast cancer stem cells. Advances in Animal and Veterinary Sciences, 9(12), 2201–2215.